Literature DB >> 12169224

Ophthalmologic migraine.

Robert F Saul1.   

Abstract

A fair portion of the diagnostic practice of the neurologist and ophthalmologist involves the deciphering of visual symptoms in patients known to have migraine, and many who at the time of their initial presentation do not. The most common visual disorder in this category, migraine with aura, has been studied extensively, but no conclusive evidence has been proven linking the visual aura, believed to result from a spreading depression, to the subsequent development of the cephalgia. Vasospasm remains controversial in the pathophysiology of migraine, but may play a role in patients who suffer more permanent or complicated neurovisual dysfunction. This paper reviews some of the current thoughts on the subject, and hopefully will stimulate the reader to explore the complex issue of this common malady.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169224     DOI: 10.1007/s11910-002-0070-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  45 in total

1.  Late-life (migrainous) scintillating zigzags without headache: one person's 27-year experience.

Authors:  C M Fisher
Journal:  Headache       Date:  1999-06       Impact factor: 5.887

2.  Migraine aura masquerading as Balint's syndrome.

Authors:  P A Shah; A Nafee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

3.  Susac syndrome: a vasospastic disorder?

Authors:  J Flammer; H Kaiser; T Haufschild
Journal:  Eur J Ophthalmol       Date:  2001 Apr-Jun       Impact factor: 2.597

4.  Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache.

Authors:  J Corbo; D Esses; P E Bijur; R Iannaccone; E J Gallagher
Journal:  Ann Emerg Med       Date:  2001-12       Impact factor: 5.721

5.  Corona phenomenon as visual aura symptom in migraine.

Authors:  K Podoll; D Robinson
Journal:  Cephalalgia       Date:  2001-09       Impact factor: 6.292

6.  Ophthalmoplegic migraine: a recurrent demyelinating neuropathy?

Authors:  J W Lance; A S Zagami
Journal:  Cephalalgia       Date:  2001-03       Impact factor: 6.292

7.  Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.

Authors:  N Toriu; A Akaike; H Yasuyoshi; S Zhang; S Kashii; Y Honda; M Shimazawa; H Hara
Journal:  Exp Eye Res       Date:  2000-04       Impact factor: 3.467

8.  Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.

Authors:  S M Bowyer; K S Aurora; J E Moran; N Tepley; K M Welch
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

Review 9.  The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation.

Authors:  A May; P J Goadsby
Journal:  J Cereb Blood Flow Metab       Date:  1999-02       Impact factor: 6.200

10.  Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction.

Authors:  L C Sanin; N T Mathew
Journal:  Cephalalgia       Date:  1993-08       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.